Case Reports in Gastroenterology
Published: September 2012
Diospyrobezoar as a Cause of Small Bowel ObstructionPadilha de Toledo A.a · Hurtado Rodrigues F.a · Rocha Rodrigues M.a · Tiemi Sato D.a · Nonose R.b · Nascimento E.F.b · Martinez C.A.R.baSão Francisco University Medical School and bDepartment of General Surgery of São Francisco University Hospital, Bragança Paulista, Brazil
Carlos Augusto Real Martinez Rua Rui Barbosa, 255 apto. 32 – Vila Boa Vista 09190-370 Santo André, SP (Brazil) E-Mail caomartinez@uol.com.br |
|
Abstract
Phytobezoar, a concretion of indigestible fibers derived from ingested vegetables and fruits, is the most common type of bezoar. Diospyrobezoar is a subtype of phytobezoar formed after excessive intake of persimmons (Diospyros kaki). We report the case of a diabetic man with a 5-day history of abdominal pain after massive ingestion of persimmons who developed signs of complicated small bowel obstruction. The patient had a previous history of Billroth II hemigastrectomy associated with truncal vagotomy to treat a chronic duodenal ulcer 14 years earlier. Since intestinal obstruction was suspected, he underwent emergency laparotomy that revealed an ileal obstruction with small bowel perforation and local peritonitis due to a phytobezoar that was impacted 15 cm above the ileocecal valve. After segmental intestinal resection, the patient had a good recovery and was discharged on the 6th postoperative day. This report provides evidence that diospyrobezoar should be considered as a possible cause of small bowel obstruction in patients who have previously undergone gastric surgery.
© 2012 S. Karger AG, Basel
Article / Publication Details
Published online: September 19, 2012
Issue release date: September – December
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 0
eISSN: 1662-0631 (Online)
For additional information: https://www.karger.com/CRG
Open Access License / Drug Dosage / Disclaimer
Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
